1771. Kartiranje in vrednotenje ekosistemskih storitev na Jelovici : projekt JeloviZaAnže Japelj, Andreja Ferreira, Andrej Kobler, Anže Martin Pintar, Katja Kavčič Sonnenschein, 2023, končno poročilo o rezultatih raziskav Ključne besede: ekosistemske storitve, vrednotenje, kartiranje, Jelovica, kaskadni model Objavljeno v DiRROS: 26.01.2024; Ogledov: 448; Prenosov: 0 |
1772. Kartiranje in vrednotenje ekosistemskih storitev na Jelovici : projekt JeloviZaAnže Japelj, Andreja Ferreira, Andrej Kobler, Anže Martin Pintar, Katja Kavčič Sonnenschein, 2023, elaborat, predštudija, študija Ključne besede: ekosistemske storitve, vrednotenje, kartiranje, Jelovica, kaskadni model Objavljeno v DiRROS: 26.01.2024; Ogledov: 428; Prenosov: 0 |
1773. High temperature friction and galling properties of nanolayered (Cr,V)N coatings and effect of V contentBojan Podgornik, Marko Sedlaček, Barbara Šetina, Miha Čekada, 2023, izvirni znanstveni članek Ključne besede: (Cr, V)N coating, galling, high-temperature tribology, hot forming, self-lubrication Objavljeno v DiRROS: 26.01.2024; Ogledov: 356; Prenosov: 187 Celotno besedilo (12,53 MB) Gradivo ima več datotek! Več... |
1774. Autologous platelet and extracellular vesicle-rich plasma as therapeutic fluid : a reviewKaja Troha, Domen Vozel, Matevž Arko, Apolonija Bedina Zavec, Drago Dolinar, Matej Hočevar, Zala Jan, Matic Kisovec, Boštjan Kocjančič, Ljubiša Pađen, Manca Pajnič, Samo Penič, Anna Romolo, Neža Repar, Vesna Spasovski, Nejc Steiner, Vid Šuštar, Aleš Iglič, Damjana Drobne, Ksenija Kogej, Saba Battelino, Veronika Kralj-Iglič, 2023, pregledni znanstveni članek Ključne besede: platelet-rich plasma, platelets, centrifugation, extracellular vesicles, small cellular particles, wound healing, regeneration, fresh-frozen plasma, intercellular signaling peptides and proteins Objavljeno v DiRROS: 26.01.2024; Ogledov: 442; Prenosov: 200 Celotno besedilo (2,37 MB) Gradivo ima več datotek! Več... |
1775. Evaluation and metrological performance of a novel ionisation vacuum gauge suitable as reference standardKarl Jousten, Sylke Bechstein, Matthias Bernien, Frédéric Boineau, N. Bundaleski, Claus Illgen, Berthold Jenninger, Janez Šetina, Ricardo A. S. Silva, Anke Stöltzel, O. M. N. D. Teodoro, Martin Wüest, 2023, izvirni znanstveni članek Ključne besede: ionisation vacuum gauge, hot cathode, sensitivity, secondary electrons, ion induced secondary electron yield Objavljeno v DiRROS: 26.01.2024; Ogledov: 384; Prenosov: 163 Celotno besedilo (3,39 MB) Gradivo ima več datotek! Več... |
1776. High sensitivity measurements of gas transport through films for food packaging and the ▫$O_2$▫ adsorption issueMarine Schott, Janez Šetina, Espedito Vassallo, Matteo Pedroni, Roberta Campardelli, Patrizia Perego, Luca Repetto, Giuseppe Firpo, 2023, izvirni znanstveni članek Ključne besede: oxygen transmission rate, food packaging, gas permeability, O2adsorption Objavljeno v DiRROS: 26.01.2024; Ogledov: 291; Prenosov: 148 Celotno besedilo (2,56 MB) Gradivo ima več datotek! Več... |
1777. Legislation on the protection of experimental animalsDragica Ornik, Milan Pogačnik, 2001, pregledni znanstveni članek Povzetek: The aim of this paper is to establish the current situation in the field of legislation on the protection of experimental animals in Slovenia. The protection of experimental animals has been regulated by the provisions of theProtection of Animals Act.1 On the basis of this act, the Instructions on Conditions for the Issuing of Authorisations for Experiments on Animals for Scientific and Research Purposes2 and the Rules on the Ethics Commission for Experiments on Animals 3 have been used. The basic protection of experimental animals is provided for by a system of permits for experiments on animals. Permits for experiments on animals are granted by the administrative authorities responsible for veterinary medicine in cases where experiments areurgently required for medical, veterinary medical, or scientific and research purposes and the results are expected to produce important new knowledge, or when the suffering of animals is ethically acceptable in comparison with what the experiment is expected to achieve; where, in cases ofbasic research, experimental aims cannot be achieved by any other method or procedure, the experiment is performed on the minimum possible number of animals of the lowest neurophysiological sensitivity and a method is used thatcauses the minimum level of suffering, pain or lasting harm. Staff involved in the execution of experiments or in the care and nursing of animals, the premises for the accommodation or rearing and provision of animals, and the installations and devices used must all comply with the set conditions. (Abstract truncated at 2000 characters) Objavljeno v DiRROS: 26.01.2024; Ogledov: 281; Prenosov: 58 Celotno besedilo (71,46 KB) |
1778. Persistent chromosomal aberrations in somatic cells in testicular cancer patients after different therapiesCvetka Bilban-Jakopin, Marjan Bilban, 2001, izvirni znanstveni članek Povzetek: Background. The damage due to radiation or chemotherapeutic agents has been estimated successfully for the last 35 years from the numbers of the chromosome changes. This finding may serve as biological dosimeter. The aim ofthe study was to find persistent chromosomal aberrations in somatic cells intesticular cancer patients after different therapies. Patients and methods. This prospective study includes 60 patients with testicular tumours. With respect to the histological results and various therapies that they were giventhey were divided into four groups. Prior to treatment, we did not detectany deviations either in the genome picture of our patients or in that of the subjects of the control group without malignant disease. The changes inthe genome of individual cells after therapy were detected by the following tests: structural chromosomal aberrations (SCA) test, sister chromatid exchange (SCE) test and micronucleus (MN) test performed on binuclear lymphocytes. (Abstract truncated at 2000 characters) Objavljeno v DiRROS: 26.01.2024; Ogledov: 256; Prenosov: 66 Celotno besedilo (169,51 KB) |
1779. Evolving strategies in the treatment of childhood rhabdomyosarcoma : Slovenian experienceŽiva Pohar-Marinšek, Jožica Anžič, Berta Jereb, 2001, izvirni znanstveni članek Povzetek: Background. Neoadjuvant chemotherapy (Cht) has changed the treatment of rhabdomyosarcoma (RMS) in children. The purpose of our study was to review thechildren treated for RMS between 1974 and 1996. Patients and methods. Fifty-one children, 1-15 years old, were included. Primary sites of tumour were: head and neck 15, orbit 6, genitourinary 12, extremity 9, torso 5 and paratesticular 4. Twelve patients were in stage 1, 10 in stage II, 26 in stage111 and 3 in stage IV. Of 43 histologically confirmed RMS 25 were embryonal, 13 alveolar, 1 botryoid, 1 spindle cell and 3 sarcoma NOS. In 8 patients, only fine needle aspiration biopsy (FNAB) was available. All patients had Cht, 29 neoadjuvant, 20 had surgery first, 40 had irradiation (RT), 2 stage IV patients had bone marrow transplant (ABMT). Multidrug Cht varied: VCR, AMD, and cyclophosphamide (VAC) were used in the 1970s, with Adriablastine (T2), methotrexat (MTX) and/or other drugs (T6, T11) in the 1980s; and in the 1990s, cyclophosphamide was replaced by ifosfamide (VAIA). The treatment was started with Cht in orbital and head and neck tumours and inthe majority of genitourinary tumours, but surgery was first in paratesticular and in the majority of extremity tumours. Results. The 3 patients with stage IV disease died. Of those with localised tumour, 34 (70%) were alive and well 5 years after treatment, 80% stage I, 75% stage II and 61%stage III. One patient died of heart failure, 3 of Cht toxicity and 1 of intereurrent disease. Conclusions. (Abstract truncated at 2000 characters) Objavljeno v DiRROS: 26.01.2024; Ogledov: 279; Prenosov: 73 Celotno besedilo (177,30 KB) |
1780. Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for SloveniaMaja Primic-Žakelj, Vera Pompe-Kirn, Fani Škrlec, Jožica Šelb-Šemerl, 2001, izvirni znanstveni članek Povzetek: Background. Valid inference on cervical cancer mortality is very difficult since - on the basis of death certificates - it is not always possible to distinguish between cervix, corpus and unspecified uterine cancer deaths. Our aim was to estimate the extent to which cervical cancer as the official cause of death reflects the true mortality from cervical cancer in Slovenia. Material and methods. The data on 2245 deaths from cervix, corpus uteri, and uterus-unspecified cancers for the period 1985-1999 were linked to the Cancer Registry of Slovenia database from the mortality database of Slovenia. Results. Officially, in the period 1985-1999, there were 878 cervical cancer deaths. The comparison of these causes of death with the cancer sites registered in the Cancer Registry revealed that they include only 87.7 % patients with a previous diagnosis of cervical cancer. Of 650 corpus uteri cancer deaths, 17.1% of patients were registered to have cervical cancer, and of 717 unspecified uterine cancer deaths, 31.4% were registered. Taking into account the correctly identified cervical cancer cases among cervical cancer deaths and misclassified cervical cancer deaths as corpus uteri and unspecified uterine, the corrected number of deaths would be 1106. Conclusions. When evaluating the impact of cervical cancer mortality from national mortality rates, the stated underestimation should be taken into account. However, this does not hold for some other cancers. Objavljeno v DiRROS: 26.01.2024; Ogledov: 286; Prenosov: 89 Celotno besedilo (199,95 KB) |